61610-65-9

Basic information

• Product Name: 1-(3-bromophenyl)propan-2-amine
• Synonyms: 1-(3-bromophenyl)propan-2-amine;BENZENEETHANAMINE, 3-BROMO-A-METHYL-;Benzeneethanamine,3-bromo-α-methyl-;1-(3-bromophenyl)-2-aminopropane;2-(3-Bromo-phenyl)-1-methyl-ethylamine
• CAS NO: 61610-65-9
• Molecular Formula: C₉H₁₂BrN
• Molecular Weight: 214.105
• Mol File: 61610-65-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(3-bromophenyl)propan-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-bromophenyl)propan-2-amine(61610-65-9)
• EPA Substance Registry System: 1-(3-bromophenyl)propan-2-amine(61610-65-9)

Safety Data

• Hazardous Substances Data: 61610-65-9(Hazardous Substances Data)

Usage

General Description

1-(3-bromophenyl)propan-2-amine is a chemical compound with the molecular formula C9H12BrN. It is a substituted amphetamine, and its structure consists of a phenyl ring with a bromine atom attached at the 3-position and a propan-2-amine group at the 1-position. 1-(3-bromophenyl)propan-2-amine has potential applications in the field of organic synthesis and pharmaceutical research, particularly in the development of new therapeutic agents. However, it is important to note that this compound may have psychoactive effects and is subject to regulation in many jurisdictions, as it may be used in the production of illicit substances. Therefore, its production, sale, and use may be subject to legal restrictions and regulations.

Upstream product

• 3132-99-8 m-bromobenzoic aldehyde 
• 15804-72-5 1-bromo-3-[2-nitroprop-1-enyl]benzene 

Downstream Products

• 133795-88-7 N-[2-(3-Bromo-phenyl)-1-methyl-ethyl]-3-phenyl-propionamide 
• 861839-93-2 [2-(3-bromo-phenyl)-1-methyl-ethyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.

SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE

The present invention relates to pyrimidinones and pyridones and derivatives thereof, and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic ? cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.